Troy Bremer
PreludeDx (United States)(US)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, BRCA gene mutations in cancer, Cancer Genomics and Diagnostics, Advances in Oncology and Radiotherapy
Most-Cited Works
- → Study of the Biologic Effects of Lapatinib, a Reversible Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, on Tumor Growth and Survival Pathways in Patients With Advanced Malignancies(2005)364 cited
- → Is blood glucose predictable from previous values? A solicitation for data.(1999)147 cited
- → A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk(2018)123 cited
- → A multimarker model to predict outcome in tamoxifen-treated breast cancer patients.(2006)66 cited
- → Validation of a Ductal Carcinoma In Situ Biomarker Profile for Risk of Recurrence after Breast-Conserving Surgery with and without Radiotherapy(2020)66 cited
- → The Pharmacogenetics of Lithium Response Depends upon Clinical Co-Morbidity(2007)59 cited
- → The Clinical Utility of DCISionRT® on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery(2021)56 cited
- → CACNA1C Polymorphisms are Associated with the Efficacy of Calcium Channel Blockers in the Treatment of Hypertension(2006)50 cited
- → Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)(2021)49 cited
- → Frequency Characterization of Blood Glucose Dynamics(2003)47 cited